Follow up on All Things Makena

BioCentury TV covers the wild week that was KV Pharmaceutical's, after the FDA nixed their plans for exclusive marketing of a form of progesterone that had previously been used widely and cheaply for decades by women to prevent premature birth.  See the video report here and read the PDF followup here.